The global veterinary molecular diagnostics market has witnessed impressive growth, with a valuation of USD 543.9 million in 2022. It is projected to expand at a compound annual growth rate (CAGR) of 7.9% from 2023 to 2031, ultimately reaching USD 1.1 billion by the end of 2031. Several factors contribute to this robust growth, including rising pet ownership, increased prevalence of vector-borne diseases, and technological advancements in molecular diagnostic techniques.
Examine key highlights and takeaways from our Report in this sample
As veterinary molecular diagnostics become increasingly essential for diagnosing a wide range of infectious diseases in both companion animals and livestock, the demand for more accurate, efficient, and accessible diagnostic tools continues to grow. This article delves into the various elements driving this market, including trends in technology, research and development, and regional insights.
Market Overview
Veterinary molecular diagnostics are crucial for identifying diseases in animals by examining their RNA, DNA, or proteins. These diagnostics are essential for detecting vector-borne diseases, respiratory pathogens, and diarrhea pathogens, which are common in both companion animals and livestock. Technologies such as Polymerase Chain Reaction (PCR), Real-time PCR, and Multiplex PCR have revolutionized veterinary diagnostics, providing precise and reliable results that traditional methods lacked.
While conventional diagnostic techniques such as enzyme-linked immunosorbent assays (ELISA) and microscopy are still in use, newer molecular techniques offer faster and more accurate results. The global shift toward molecular diagnostics is largely due to the advancements in technology and the high demand for early and precise diagnosis in veterinary care.
Technologies Driving Growth
The key technologies in the veterinary molecular diagnostics market include:
- Conventional PCR: A widely used method for amplifying DNA samples, helping detect pathogens.
- Singleplex PCR: Targets a single pathogen at a time for more focused diagnostic testing.
- Multiplex PCR: Allows for the detection of multiple pathogens in a single test, making it cost-effective and time-efficient.
- Real-time PCR: Offers real-time results with greater sensitivity and specificity.
These technologies are enabling veterinary professionals to diagnose and treat infections in animals more effectively, ensuring better health outcomes for both pets and livestock.
Market Drivers
1. Growth in Pet Ownership
Over the last few decades, the number of companion animals has grown significantly. In the U.S., for instance, approximately 66% of households own pets, equating to around 86.9 million households. As pet ownership continues to increase, the demand for veterinary molecular diagnostics is also rising. Pets, particularly dogs and cats, are susceptible to a wide range of diseases, and owners are increasingly willing to invest in advanced diagnostic tools to ensure their pets’ health.
Moreover, there is an increasing trend of spending on pet healthcare, including obesity management. According to the Association for Pet Obesity Prevention (APOP), about 59% of U.S. dogs and 61% of cats were classified as overweight or obese in 2022. As obesity often leads to other health complications, the demand for precise diagnostics and treatments, including veterinary molecular diagnostics, continues to rise.
2. Rise in Prevalence of Vector-borne Diseases
Another major driver of the veterinary molecular diagnostics market is the rising prevalence of vector-borne diseases. These diseases, transmitted by insects such as ticks, mosquitoes, and fleas, are increasingly being reported in both dogs and cats worldwide. Some common vector-borne diseases include Lyme disease, heartworm disease, and babesiosis, which pose significant threats to animal health.
As global warming expands the range of vectors, these diseases are becoming more widespread, driving the need for efficient and accurate diagnostic methods to detect infections early. Veterinary molecular diagnostics enable faster and more reliable detection of vector-borne pathogens, helping reduce transmission and improve treatment outcomes.
3. Technological Advancements
Advancements in molecular diagnostic technologies have also played a significant role in shaping the growth of the veterinary molecular diagnostics market. The advent of DNA sequencing platforms, high-throughput data generation, and computational genomics has enhanced the precision of diagnostics. Furthermore, innovations like AI-assisted diagnostics have led to the development of advanced diagnostic tools capable of delivering consistent and accurate results within minutes.
As these technologies evolve, they are making veterinary diagnostics more accessible and cost-effective, ensuring better patient care and driving market demand.
Segmentation of the Veterinary Molecular Diagnostics Market
By Product Type
- Instruments & Software: These tools are essential for conducting molecular tests, supporting the growing demand for advanced diagnostic techniques in veterinary care.
- Kits & Reagents: Ready-to-use kits are gaining significant traction as they simplify workflows and enhance ease of use, particularly in point-of-care settings.
- Services: Many veterinary clinics and laboratories offer testing services, making it easier for pet owners and livestock farmers to access molecular diagnostics.
By Technology
- Conventional PCR: Although more traditional, this method is still widely used for pathogen detection.
- Singleplex PCR: Targeting a single pathogen, this method is cost-effective but limited in scope.
- Multiplex PCR: This technique is increasingly preferred for its ability to detect multiple pathogens in a single test.
- Real-time PCR: Offering real-time detection, this technology is known for its high sensitivity and accuracy.
By Disease Type
- Vector-borne Diseases: The increase in vector-borne diseases such as Lyme disease, heartworm, and ehrlichiosis is driving the demand for effective molecular diagnostics.
- Respiratory Pathogens: Respiratory diseases like kennel cough and feline respiratory infections are prevalent in companion animals, leading to a rise in diagnostic testing.
- Diarrhea Pathogens: Pathogens causing gastrointestinal issues are common in both pets and livestock, further driving the need for molecular diagnostic solutions.
By Animal Type
- Companion Animals: This segment includes pets like dogs, cats, and small mammals, which are increasingly affected by a variety of infectious diseases.
- Livestock Animals: Larger animals, including cattle, sheep, and pigs, are often affected by diseases that require accurate molecular diagnostics for better management and treatment.
Regional Outlook
North America: The Dominant Market
North America held the largest share of the veterinary molecular diagnostics market in 2022. The rising number of companion animals and increased pet healthcare spending in regions like the U.S. contribute to market growth. Moreover, the presence of leading players such as IDEXX Laboratories and Zoetis in this region further boosts its dominance.
Asia Pacific: Emerging Market
The Asia Pacific region is expected to witness the fastest growth in the veterinary molecular diagnostics market during the forecast period. Countries like China and India are experiencing rapid growth in the adoption of veterinary care and diagnostic tools, driven by rising awareness, improving veterinary infrastructure, and increased livestock farming activities.
Key Players in the Market
Prominent players in the veterinary molecular diagnostics market are continuously innovating and expanding their product offerings to strengthen their market position. Key companies include:
- IDEXX Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Zoetis, Inc.
- Neogen Corporation
- bioMérieux SA
- QIAGEN N.V.
- Mars, Incorporated
Recent Developments
- In January 2024, IDEXX Laboratories launched the IDEXX inVue Dx Cellular Analyzer, a groundbreaking tool for diagnosing cytologic changes in ear and blood samples.
- Zoetis announced the expansion of its Vetscan Imagyst platform to include AI-powered urine sediment analysis for in-clinic diagnostic applications.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
